What is Eikon Therapeutics, Inc. 's total liabilities & equity?

Eikon Therapeutics, Inc. (EIKN) reported total liabilities & equity of $850.83M in Q1 2026.

What does total liabilities & equity mean?

Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

MYR GroupMYRG

$1.67B+9.9%

Establishment LabsESTA

$351.04M+5.3%

Acadia Realty TrustAKR

$4.53B-4.3%

Mcgrath RentcorpMGRC

$2.38B+6.1%

First Busey CorporationBUSE

$18.04B-7.3%

InnospecIOSP

$1.82B+2.5%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's total liabilities & equity?: Eikon Therapeutics, Inc. (EIKN) reported total liabilities & equity of $850.83M in Q1 2026.
What does total liabilities & equity mean?: Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.